ZANDI HUDSPETH: Open Payments
NPI 1992076434 · AMITE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 47 payments from 13 companies in 2025. Trend: 2023 $905 · 2024 $648 · 2025 $873
Food & beverage: $873
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $215 |
| ABBVIE INC. | 14 | $206 |
| Lilly USA, LLC | 7 | $114 |
| Boston Scientific Corporation | 1 | $93 |
| Supernus Pharmaceuticals, Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| PFIZER INC. | 2 | $33 |
| Lundbeck LLC | 2 | $32 |
| Dexcom, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
Products named: VRAYLAR, Ozempic, MOUNJARO, WATCHMAN FLX, Qelbree, Rybelsus, BREZTRI, NURTEC ODT.
Industry payments across LA — which companies pay providers there.
